Title : Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.

Pub. Date : 2020 Oct 24

PMID : 33098638






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance. Tamoxifen cyclin dependent kinase 2 Homo sapiens
2 Subsequently, MAFG-AS1 and CDK2 were found to be up-regulated in tamoxifen-resistant MCF-7 cells. Tamoxifen cyclin dependent kinase 2 Homo sapiens
3 Cross-talk between the ER signaling pathway and cell cycle conducted by MAFG-AS1 and CDK2 could promote tamoxifen resistance. Tamoxifen cyclin dependent kinase 2 Homo sapiens